MediWound Ltd. (MDWD) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 1.48M | 1.87M | 5.43M | 5.71M | 3.96M | 5.84M | 4.36M | 5.06M | 4.96M | 5.34M | 4.78M | 4.77M |
| Revenue Growth % | -62.71% | -68.03% | 24.66% | 12.74% | -20.33% | 9.4% | -8.81% | 6.08% | 30.67% | -54.05% | -17.7% | 2.25% |
| Cost of Goods Sold | 1.15M | 1.59M | 4.53M | 4.37M | 3.22M | 4.94M | 3.68M | 4.62M | 4.36M | 4.62M | 3.88M | 3.64M |
| COGS % of Revenue | 78.1% | 85.11% | 83.5% | 76.49% | 81.34% | 84.54% | 84.45% | 91.17% | 87.77% | 86.53% | 81.24% | 76.18% |
| Gross Profit | 323K | 278K | 896K | 1.34M | 738K | 903K | 677K | 447K | 607K | 719K | 896K | 1.14M |
| Gross Margin % | 21.9% | 14.89% | 16.5% | 23.51% | 18.66% | 15.46% | 15.55% | 8.83% | 12.23% | 13.47% | 18.76% | 23.82% |
| Gross Profit Growth % | -56.23% | -69.21% | 32.35% | 200.22% | 21.58% | 25.59% | -24.44% | -60.69% | -26.51% | -91.19% | -63.19% | 2.16% |
| Operating Expenses | 8.3M | 8.09M | 7.42M | 7.06M | 5.96M | 6.99M | 5.76M | 4.93M | 4.34M | 4.61M | 3.92M | 5.14M |
| OpEx % of Revenue | 562.92% | 433.37% | 136.69% | 123.65% | 150.77% | 119.62% | 132.22% | 97.39% | 87.45% | 86.42% | 82.1% | 107.77% |
| Selling, General & Admin | 3.56M | 3.33M | 3.96M | 3.57M | 3.07M | 3.77M | 3.23M | 3.03M | 2.87M | 2.56M | 2.61M | 3.12M |
| SG&A % of Revenue | 241.15% | 178.31% | 72.87% | 62.49% | 77.7% | 64.59% | 74.26% | 59.91% | 57.84% | 47.9% | 54.69% | 65.37% |
| Research & Development | 5.18M | 4.48M | 3.46M | 3.49M | 2.89M | 2.99M | 2.52M | 1.9M | 1.47M | 1.81M | 1.53M | 2.02M |
| R&D % of Revenue | 351.53% | 239.85% | 63.82% | 61.16% | 72.97% | 51.13% | 57.96% | 37.49% | 29.61% | 33.87% | 32.1% | 42.41% |
| Other Operating Expenses | -439K | 284K | 0 | 0 | 4K | 228K | 0 | 0 | 0 | 248K | -224K | 0 |
| Operating Income | -7.98M | -7.81M | -6.53M | -5.72M | -5.22M | -6.08M | -5.08M | -4.48M | -3.73M | -3.89M | -3.02M | -4.01M |
| Operating Margin % | -541.02% | -418.48% | -120.19% | -100.14% | -132.11% | -104.16% | -116.67% | -88.56% | -75.22% | -72.95% | -63.34% | -83.95% |
| Operating Income Growth % | -52.73% | -28.44% | -28.42% | -27.48% | -39.93% | -56.21% | -67.97% | -11.9% | 14.44% | -283.42% | 13.82% | -9.06% |
| EBITDA | -7.6M | -7.12M | -6.11M | -5.32M | -4.87M | -5.69M | -4.72M | -4.13M | -3.37M | -3.55M | -2.69M | -3.69M |
| EBITDA Margin % | -515.39% | -381.52% | -112.49% | -93.24% | -123.06% | -97.36% | -108.38% | -81.51% | -67.81% | -66.47% | -56.24% | -77.35% |
| EBITDA Growth % | -56.19% | -25.27% | -29.39% | -28.96% | -44.59% | -60.26% | -75.73% | -11.78% | 17.11% | -247.4% | 15.32% | -10.37% |
| D&A (Non-Cash Add-back) | 378K | 690K | 418K | 394K | 358K | 397K | 361K | 357K | 368K | 346K | 339K | 315K |
| EBIT | -7.98M | -5.86M | -6.53M | -5.72M | -5.22M | -16.11M | -5.08M | -4.48M | -3.73M | 5.29M | -3.02M | -4.01M |
| Net Interest Income | 0 | 690K | 3.93M | -7.56M | 4.5M | 2.21M | -5.18M | -1.82M | -5.97M | 2.27M | 877K | 4.93M |
| Interest Income | 0 | 690K | 3.93M | 429K | 4.5M | 2.21M | 0 | 582K | 0 | 2.27M | 877K | 5.83M |
| Interest Expense | 0 | 0 | 0 | 7.99M | 0 | 0 | 5.18M | 2.4M | 5.97M | 0 | 0 | 893K |
| Other Income/Expense | 5.01M | 703K | 3.93M | -7.56M | 4.5M | 2.19M | -5.18M | -1.82M | -5.97M | 2.27M | 877K | 4.93M |
| Pretax Income | -2.97M | -7.11M | -2.6M | -13.28M | -721K | -3.89M | -10.26M | -6.31M | -9.71M | -1.62M | -2.15M | 928K |
| Pretax Margin % | -201.29% | -380.82% | -47.87% | -232.66% | -18.23% | -66.61% | -235.61% | -124.57% | -195.51% | -30.4% | -44.97% | 19.44% |
| Income Tax | -17K | 73K | 53K | 38K | 5K | 18K | 21K | -2K | 24K | 120K | 48K | 12K |
| Effective Tax Rate % | 0.57% | -1.03% | -2.04% | -0.29% | -0.69% | -0.46% | -0.2% | 0.03% | -0.25% | -7.39% | -2.23% | 1.29% |
| Net Income | -2.95M | -7.18M | -2.65M | -13.32M | -726K | -3.91M | -10.28M | -6.3M | -9.73M | -1.74M | -2.2M | 916K |
| Net Margin % | -200.14% | -384.73% | -48.85% | -233.32% | -18.36% | -66.92% | -236.1% | -124.53% | -195.99% | -32.65% | -45.98% | 19.19% |
| Net Income Growth % | -306.61% | -83.8% | 74.21% | -111.23% | 92.54% | -124.21% | -368.21% | -788.32% | -163.44% | 76.63% | 47.7% | 121.04% |
| Net Income (Continuing) | -2.95M | -7.18M | -2.65M | -13.32M | -726K | -3.91M | -10.28M | -6.3M | -9.73M | -1.74M | -2.2M | 916K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.23 | -0.56 | -0.24 | -1.23 | -0.07 | -0.36 | -0.98 | -0.68 | -1.05 | -0.19 | -0.24 | 0.10 |
| EPS Growth % | -242.26% | -55.56% | 75.51% | -80.88% | 93.6% | -89.47% | -308.33% | -783.42% | -138.64% | 83.9% | 72.73% | 110.82% |
| EPS (Basic) | -0.23 | -0.56 | -0.24 | -1.23 | -0.07 | -0.36 | -0.98 | -0.68 | -1.05 | -0.19 | -0.24 | 0.10 |
| Diluted Shares Outstanding | 12.87M | 12.83M | 11.02M | 10.84M | 10.8M | 10.79M | 10.51M | 9.28M | 9.23M | 9.22M | 9.22M | 9.21M |
| Basic Shares Outstanding | 12.87M | 12.83M | 11.02M | 10.84M | 10.37M | 10.79M | 10.51M | 9.28M | 9.23M | 9.22M | 9.22M | 9.21M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |